Dr. Bishoy M. Faltas
@FaltasLab
Physician-Scientist. Chief Research Officer @EngIPM. Gellert-John P. Leonard Scholar, Associate Professor @WeillCornell. Husband & father. RTs ≠ endorsements
Good time to read our Tweetorial/ X-planation of our nature.com/articles/s4158… paper now featured on the cover of @Nature!
🚀Big News! Excited to share our work “The Interplay of Mutagenesis and ecDNA Shapes Urothelial Cancer Evolution” published in @Nature! nature.com/articles/s4158…
Giant study finds a research field that’s mostly reproducible. That the majority of findings look verifiable speaks to the power of the scientific method, excellence of peer review and the integrity of researchers worldwide. Something we know all along. nature.com/articles/d4158…
These parents set up biotechnology companies, hoping to cure their children's illnesses go.nature.com/44TrPAw
STARTING SOON—Join us for the next SBUR Summer Trainee Webinar! Open to all SBUR members, this new platform highlights trainee research. The bladder diseases installment begins today at 4:00 PM ET. Secure Your Spot Before It's Too Late: buff.ly/6aU7XDu #SBUR
In 3 prospective cohorts comprised of 2.2 million individuals from UK and China, #Diabetes increases the risk of #LiverCancer #PancreaticCancer #BladderCancer New @JNCI_Now study: academic.oup.com/jnci/advance-a…
I really enjoyed this conversation with @UroDocAsh @UroToday where we discussed how AI and deep learning are transforming how we think about cancer treatment, especially in bladder cancer. We discussed our work using AI to integrate data streams from the lab and the clinic to…
Multimodal deep learning predicts #BladderCancer response to neoadjuvant chemotherapy. @FaltasLab @WeillCornell joins @UroDocAsh @MDAndersonNews to discuss a deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in #MIBC. #WatchNow >…
Launched today- the Weill Cancer Hub West -supporting transformative cancer research collaborations btw @UCSF & @Stanford. Honored to co-lead, with @longlabstanford, our team who will study the impact of diet on pancreatic cancer initiation, progression and therapy response.
Backed by a $100M gift from Joan and Sandy Weill, UCSF and @StanfordMed @StanfordCancer are launching Weill Cancer Hub West, a $200M initiative in team science to accelerate cancer research and improve care over the next decade. tiny.ucsf.edu/ppVRqt
A paper in @Nature reports an artificial intelligence-based tool that can predict missing parts of Latin inscriptions from the Roman period. The tool, named Aeneas, can relate the texts to others, offering contextualization for historians. go.nature.com/4kX1K9I
There are much more structural variants within our genomes than previously conceived, >26,000 per person nature.com/articles/s4158… nature.com/articles/s4158…
One-shot prime genome editing ("CRISPR 3.0") of the brain in vivo corrected AHC, a rare genetic disorder, in the mouse model. Another big step forward in the genome editing field. @CellCellPress @davidrliu and colleagues cell.com/cell/fulltext/…
Be sure to check out the @WCMEnglanderIPM's response in @oncodaily to the @NIH call for a national #AI strategy to chart a course from today’s #analytics to a future of autonomous AI—a fundamental shift for #biomedicine. oncodaily.com/blog/olivier-e…
Range extender mediates long-distance enhancer activity nature.com/articles/s4158…
Writing is thinking | Nature Reviews Bioengineering nature.com/articles/s4422…
Important caveat about AI x Bio. In some biology fields “ we simply don’t know enough to teach the machine learning algorithms yet. Not to mention that some of what we’d be teaching them is just wrong to start with” | Science | AAAS science.org/content/blog-p…
Detecting Foldback Artifacts in Long Reads biorxiv.org/content/10.110…
With aging populations, a changing climate, and disruptive tech like AI, we've never needed science more to tackle the world's biggest challenges. Great to see the EU proposing to double research funding to €175B to find the solutions we need. science.org/content/articl…
Longer follow up for Enfortumab Vedotin & Pembro in urothelial cancer @Annals_Oncology shows mOS at nearly 3 yrs (34 mnths) with 50% of responses (68%) continuing at 2 years! Experience in tox management is important. Duration of therapy uncertain in CR gbr01.safelinks.protection.outlook.com/?url=https%3A%…
ChatGPT Agent: our first AI with access to a text browser, a visual browser, and a terminal. Rolling out in ChatGPT Pro, Plus, and Team today.
Wow!!! Big advance for women with pathogenic mitochondrial DNA variants in @NEJM! nejm.org/doi/full/10.10… nejm.org/doi/full/10.10…